Ipca Laboratories incorporates wholly-owned German subsidiary

Ipca Laboratories Ltd. announced on October 16, 2025, the establishment of a wholly-owned subsidiary named "Ipca Pharmaceuticals GmbH" in Germany. This new entity has an initial paid-up capital of € 25,000.

The primary objectives of Ipca Pharmaceuticals GmbH include holding product registrations, participating in institutional and other business activities, and undertaking the distribution of generic formulations within Germany. This move indicates Ipca Laboratories' expansion strategy into the European market.